Clinical Trials

Inclusion Criteria: 

• Female with a new diagnosis of breast cancer (stage I-III).
• Age 20 or older.
• Able to read and write in English.
• Chemotherapy naïve and beginning the first cycle of moderately or highly emetogenic chemotherapy (Taxotere + Cyclophosphamide treatment +/- Trastuzumab). Patients who have not received chemotherapy for five years or more are considered chemotherapy naïve.

Exclusion Criteria:   

• Metastatic disease
• Cognitive impairment, based on clinician assessment, that would prevent completing measures.
• Concurrent radiation therapy or radiation therapy within the last three months.
• GI co-morbidities (i.e., irritable bowel syndrome, gastroesophageal reflux disease) or bowel surgery within the last three months.
• A stoma preventing stool collection from the large intestine (i.e., ileostomy).

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 8/9/23. Questions regarding updates should be directed to the study team contact.